UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000022895
Receipt No. R000026387
Official scientific title of the study Examination of rehabilitation with feedback for patients with hematological cancer
Date of disclosure of the study information 2016/06/27
Last modified on 2016/06/27 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Examination of rehabilitation with feedback for patients with hematological cancer
Title of the study (Brief title) Examination of rehabilitation with feedback for patients with hematological cancer
Region
Japan

Condition
Condition patients with hematological cancer
Classification by specialty
Hematology and clinical oncology Rehabilitation medicine
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 to examine the effect of rehabilitation with feedback forpatients with hematological cancer
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes physical activity
Key secondary outcomes 1.muscle strength/walking ability
2.anxiety/depression(HADS)
3.QOL(EORTC QLQ c-30)

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 Control:normar rehabilitation
Interventions/Control_2 Interventions:rehabilitation with feedback
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria The patients with hematologic cancer who scheduled for chemotherapy , they has been prescribed physical therapy
Key exclusion criteria 1)considered inadequate by the investigator
2)has severe complications
3)has severe dysfunction(cardiac,respiratory,hapatic,renal)
4)has diseases that affects physical activity (Cerebrovascular disease,Orthopedic disease)
5)has dementia
Target sample size 184

Research contact person
Name of lead principal investigator Shun Ishii
Organization Nagasaki University Hospital
Division name Department of Rehabilitation Medicine
Address 1-7-1 Sakamoto, Nagasaki
TEL 095-819-7258
Email shun331@nagasaki-u.ac.jp

Public contact
Name of contact person Shun Ishii
Organization Nagasaki University Hospital
Division name Department of Rehabilitation Medicine
Address 1-7-1 Sakamoto, Nagasaki
TEL 095-819-7258
Homepage URL
Email shun331@nagasaki-u.ac.jp

Sponsor
Institute Nagasaki University Hospital
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization Japan Society for the Promotion of Science
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 06 Month 27 Day

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2016 Year 06 Month 27 Day
Anticipated trial start date
2016 Year 06 Month 27 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 06 Month 27 Day
Last modified on
2016 Year 06 Month 27 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026387